HUPO Connect 2020 Program

Important Notice: Sessions 1B through 9B are repeated sessions to accommodate all timezones. Please note that the program is subject to change without notice. All sessions are listed in UTC time (Coordinated Universal Time). Please view the World Clock Converter for your timezone.

Click here to view the Schedule at a Glance
Expand All +
  • October 19, 2020


  • October 20, 2020


  • October 21, 2020


  • October 22, 2020


  • Opening Remarks
    Introduction to the HUPO Connect 2020 Platform and Programme
    Global Proteomic Exploration of COVID-19: Infection and Therapeutics, Stephen Pennington, Ireland

  • Beyond the Genome: Facilitating Precision Medicine with Targeted Proteomic Assays, Amanda Paulovich, United States
    Development of Saliva Protein Biomarkers to Detect and Monitor Oral Cancer, Jau-Song Yu, Taiwan
    Discovery of Precision Medicines and Chemical Probes for Cancer: Role of Proteomics and Genomics, Paul Workman, United Kingdom

  • Biology, Pathogenesis, and Treatment of Viral Infections Viewed Through the Lens of Proteomics, Ileana Cristea, United States
    Multiplex and High Throughput Analysis of Immune Response Against Covid-19, Sophia Hober, Sweden
    Structural Proteomics Investigations of Viral Antigen Proteins, Perdita Barran, United Kingdom

    This session is supported by:
    Click Here to Watch Video

  • Signaling in Space and Time Through Proximity-dependent Biotinylations, Anne-Claude Gingras, Canada
    Harnessing Glycomics and Glycoproteomics for Cardiovascular Precision Medicine, Rebekah Gundrey, United States
    The wondrous world of molecules in context: Image-and-omics at the single cell level, Ron Heeren, The Netherlands

  • Speakers: Lisa Jones, United States
    Moderators: Rob Rivers, United States, Alexander Hogrebe, United States

  • Explore the Proteome using CETSA MS, Tomas Friman

    This industry seminar is supported by:

  • TMT-based comparative interactomics of SARS-CoV-2 and coronavirus non-structural protein homologs to identify shared and unique host-cell dependencies, Lars Plate
    Providing COVID-19 clarity using TMT reagents for precision measurements, Ryan Bomgarden

    This industry seminar is supported by:

  • Beyond the Genome: Facilitating Precision Medicine with Targeted Proteomic Assays, Amanda Paulovich, United States
    Development of Saliva Protein Biomarkers to Detect and Monitor Oral Cancer, Jau-Song Yu, Taiwan
    Discovery of Precision Medicines and Chemical Probes for Cancer: Role of Proteomics and Genomics, Paul Workman, United Kingdom

  • Biology, Pathogenesis, and Treatment of Viral Infections Viewed Through the Lens of Proteomics, Ileana Cristea, United States
    Multiplex and High Throughput Analysis of Immune Response Against Covid-19, Sophia Hober, Sweden
    Structural Proteomics Investigations of Viral Antigen Proteins, Perdita Barran, United Kingdom

    This session is supported by:
    Click Here to Watch Video

  • Signaling in Space and Time Through Proximity-dependent Biotinylations, Anne-Claude Gingras, Canada
    Harnessing Glycomics and Glycoproteomics for Cardiovascular Precision Medicine, Rebekah Gundrey, United States
    The wondrous world of molecules in context: Image-and-omics at the single cell level, Ron Heeren, The Netherlands

  • ATLANTiC: Proteome Activity Landscapes of Tumor Cell Lines Determine Drug Responses, Bernhard Kuster, Germany
    Deep Visual Proteomics for Systems Biology, Matthias Mann, Germany
    Regulation of Hypoxia-inducible Factors by Oxygen-dependent Degradation, Gregg Semenza, United States

  • Development of a Pan-coronavirus Proteome Serological Assay, Josh LaBaer, United States
    The 3D Proteome and the Potential for Conformational Biomarkers, John Yates, United States
    Protein Biomarker Quantification by LCMS Enabling Gene Therapy and Biotherapeutics Development in Biopharma, Hendrik Neubert, United States

  • In-cell Protein Footprinting: A Tool for Structural Biology Across the Proteome, Lisa Jones, United States
    Single-cell Proteomic and Transcriptomic Analysis of Macrophage Heterogeneity, Nikolai Slovov, United States
    Mass Spectrometry Proteomics for Single-cell Neuroscience, Peter Nemes, United States

  • Live Annual General Meeting and Kahoot Quiz

  • The Synergies of Mass Spectrometry and Informatics, John R. Yates
    New prm-PASEF® method for highly multiplexed targeted quantitative proteomics for clinical research, Gunnar Dittmar

    This industry seminar is supported by:

  • ATLANTiC: Proteome Activity Landscapes of Tumor Cell Lines Determine Drug Responses, Bernhard Kuster, Germany
    Deep Visual Proteomics for Systems Biology, Matthias Mann, Germany
    Regulation of Hypoxia-inducible Factors by Oxygen-dependent Degradation, Gregg Semenza, United States

  • Development of a Pan-coronavirus Proteome Serological Assay, Josh LaBaer, United States
    The 3D Proteome and the Potential for Conformational Biomarkers, John Yates, United States
    Protein Biomarker Quantification by LCMS Enabling Gene Therapy and Biotherapeutics Development in Biopharma, Hendrik Neubert, United States

  • In-cell Protein Footprinting: A Tool for Structural Biology Across the Proteome, Lisa Jones, United States
    Single-cell Proteomic and Transcriptomic Analysis of Macrophage Heterogeneity, Nikolai Slovov, United States
    Mass Spectrometry Proteomics for Single-cell Neuroscience, Peter Nemes, United States

  • Speakers: Benjamin A. Garcia, United States and Ruth Huttenhain, United States
    Moderators: Mathieu Lavallée-Adam, Canada

  • Live Annual General Meeting and Kahoot Quiz

  • Speakers: Bernard Delanghe, United States, and James Anson, United Kingdom
    Moderator: Maike Langini, Germany and Andreas Hober, Sweden

  • Rapid Complex-centric Quantitative Profiling of the Monocyte-macrophage Axis, Ben Collins, United Kingdom
    Proteomes in 3D, Paola Picotti, Switzerland
    In-cell Architecture of an Actively Transcribing-translating Expressome, Juri Rappsilber, United Kingdom

  • Computational Discovery of Tumor Antigens from Mass Spectrometry Data, Bing Zhang, United States
    Exploring the Landscape of Pan-cancer Proteogenomics with Cancer Cell Lines, Rebecca Poulos, Australia
    Genetics of Protein Abundance in Human TIssues, Hua Tang, United States

  • Defining Proteoform Landscape by Novel Top-down Proteomics Strategies, Ying Ge, United States
    Building an Ecosystem to Measure and Understand Human Biology at the Proteoform Level, Neil Kelleher, United States
    Challenges to Unveil Human Proteoform Landscape by Shotgun Proteomics Approaches, Yasushi Ishihama, Japan

  • More details coming soon!
    This industry seminar is supported by:

  • Multiplexed Proteomics for Understanding Molecular Biology, Mikhail Savitski
    Characterizing Cellular Hierarchies Using Quantitative Single-Cell Proteomics, Erwin Schoof

    This industry seminar is supported by:

  • Rapid Complex-centric Quantitative Profiling of the Monocyte-macrophage Axis, Ben Collins, United Kingdom
    Proteomes in 3D, Paola Picotti, Switzerland
    In-cell Architecture of an Actively Transcribing-translating Expressome, Juri Rappsilber, United Kingdom

  • Computational Discovery of Tumor Antigens from Mass Spectrometry Data, Bing Zhang, United States
    Exploring the Landscape of Pan-cancer Proteogenomics with Cancer Cell Lines, Rebecca Poulos, Australia
    Genetics of Protein Abundance in Human TIssues, Hua Tang, United States

  • Defining Proteoform Landscape by Novel Top-down Proteomics Strategies, Ying Ge, United States
    Building an Ecosystem to Measure and Understand Human Biology at the Proteoform Level, Neil Kelleher, United States
    Challenges to Unveil Human Proteoform Landscape by Shotgun Proteomics Approaches, Yasushi Ishihama, Japan

  • Closing Remarks
    Announcement of the PhD Poster and ECR Manuscript Winners
    HUPO Awards
    The Story of Proteins
    Announcement of HUPO 2021 Programme

  • Near-term future planning/development update, Chris Overall, Ileana Cristea, Cecilia Lindskog,
    Eric Deutsch/Lydie Lane, Dan Chan, Susan Weintraub
    Discussions All

  • Chair: Ruedi Aebersold, Switzerland
    Break out groups to discuss the following 3 topics:
    1. How can proteomics make the link from measuring molecules (proteins) to biological function?
    2. How can HPP explore the full extent of the complexities of the proteome and translate knowledge into new biology
    3. What are the bottlenecks to increase the uptake and dissemination of proteomics?

    Format:
    Introduction of topics: Ruedi Aebersold, Switzerland
    Parallel discussion of topics in parallel break out sessions: All
    Reporting back to plenum: Rapporteurs
    General discussion: All

  • Chair: Robert Moritz, United States
    Human Cell Atlas, Emma Lundberg, Sweden
    Proteoforms in the Context of the Human Cell Atlas,Neil Kelleher, United States
    PDPM (CN-HPP Proteomics Driven Precision Medicine), Fuchu He, China
    From CPTAC to Moonshot to ICPC (Proteogenomics Precision Oncology), Henry Rodriguez, United States
    HuBMAP, HTAN, GTEx and other US Based consortia projects, Mike Snyder, United States
    Discussion, All
    Current and Incoming HUPO Presidents’ HPP Reflections, Stephen Pennington, Ireland, Yu-Ju Chen, Taiwan

For more details on the virtual Industry Seminars, please visit the Confirmed Sponsors & Virtual Seminars page.